Correlations between molecular profile and radiologic pattern in oligodendroglial tumors

Neurology

Volumn 63, Issue 12, 2004, Pages 2360-2362

  Laigle Donadey, F ^a   Martin Duverneuil, N ^a   Lejeune, J ^a   Criniere E ^b   Capelle, L ^a   Duffau, H ^a   Cornu, P ^a   Broet P ^c   Kujas, M ^a,b   Mokhtari, K ^a,b   Carpentier, A ^a,b   Sanson, M ^a,b   Hoang Xuan, K ^a,b   Thillet, J ^b   Delattre, J Y ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAPLASTIC CARCINOMA; ANAPLASTIC OLIGODENDROGLIOMA; BRAIN RADIOGRAPHY; CANCER CLASSIFICATION; CANCER GRADING; CHROMOSOME 1P; CHROMOSOME LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FRONTAL LOBE; GENE EXPRESSION PROFILING; GENE MUTATION; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; OLIGODENDROGLIOMA; PARIETAL LOBE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TEMPORAL LOBE; TUMOR LOCALIZATION;

EID: 19944411123     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000148642.26985.68     Document Type: Review

References (15)

1. Fortin D, Cairncross JG, Hammond RR. Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment. Neurosurgery 1999;45:1279-1291.
2. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 1997;79:1381-1393.
3. Ino Y, Betensky RA, Zlatescu MC, et al. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 2001;7:839-845.
4. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. JNCI 1998;90:1473-1479.
5. Hoang-Xuan K, Capelle L, Kujas M, et al. Temozolomide as initial treatment for adults with low grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome lp deletions. J Clin Oncol 2004;22:3133-3138.
6. Zlatescu MC, TheraniYazdi A, Sasaki H, et al. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 2001;61:6713-6715.
7. Mueller W, Hartmann C, Hoffmann A, et al. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol 2002;161:313-319.
8. Möller TB, Reif E. Pocket atlas of sectional anatomy, computed tomography and magnetic resonance imaging, vol. 1: head, neck, spine and joints. 2nd ed. Stuttgart: Thieme Medical, 1994.
9. Hoang-Xuan K, He J, Huguet S, et al. Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression. Neurology 2001;57:1278-1281.
10. Sasaki H, Zlatescu MC, Betensky RA, et al. Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma." J Neuropathol Exp Neurol 2002;61:58-63.
11. Lleonart ME, Garcia-Foncillas J, Sanchez-Prieto R, et al. Microsatellite instability and p53 mutations in sporadic right and left colon carcinoma: different clinical and molecular implications. Cancer 1998;83:889-895.
12. Spassky N, Goujet-Zalc C, Parmantier E, et al. Multiple restricted origin of oligodendrocytes. J Neurosci 1998;18:8331-8343.
13. Spassky N, Heydon K, Mangatal A, et al. Sonic hedgehog-dependent emergence of oligodendrocytes in the telencephalon: evidence for a source of oligodendrocytes in the olfactory bulb that is independent of PDGFRα signaling. Development 2001;128:4993-5004.
14. Thomas JL, Spassky N, Perez Villegas EM, et al. Spatiotemporal development of oligodendrocytes in the embryonic brain. J Neurosci Res 2000;59:471-476.
15. Honnorat J, Aguera M, Zalc B, et al. POP66, a paraneoplastic encephalomyelitis-related antigen, is a marker of adult oligodendrocytes. J Neuropathol Exp Neurol 1998;57:311-322.